Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals Inc.
WKN: 881535 / Symbol: REGN / Name: Regeneron / Aktie / Biotechnologie & medizinische Forschung / Large Cap /
924,80 €
1,86 %
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for REGN provided by MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $1,150.00 price target on the stock.
Ratings data for REGN provided by MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
Ratings data for REGN provided by MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target raised by analysts at Royal Bank of Canada from $1,185.00 to $1,200.00. They now have an "outperform" rating on the stock.
Ratings data for REGN provided by MarketBeat
Neueste Beiträge
Bank_of_America_Co_ in Seagate Technology.Holdings plc diskutieren